New England Journal of Medicine

Immune therapy induces remission for many with ALL

(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published ...

Oct 16, 2014
popularity not rated yet | comments 0

Data sharing in pharmaceutical industry shows progress

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Oct 16, 2014
popularity not rated yet | comments 0